Çàðåãèñòðèðîâàòüñÿ

Ïîõîæèå òåìû

  1. Ïîñëå îïåðàöèè íà âàðèêîöåëå...
    îò Ãðèã â ðàçäåëå Óðîëîã-àíäðîëîã
    Îòâåòîâ: 40
    : 27.01.2015, 15:28
  2. áîëè â îáîèõ ÿè÷êàõ ïîñëå îïåðàöèè íà âàðèêîöåëå
    îò Àíîíèì â ðàçäåëå Óðîëîã-àíäðîëîã
    Îòâåòîâ: 1
    : 07.08.2006, 15:17
  3. Îòâåòîâ: 2
    : 24.08.2004, 12:41
  4. Îòâåòîâ: 1
    : 20.08.2004, 10:38
  5. Îòâåòîâ: 1
    : 04.08.2004, 04:25
  1. kumatkan
    #31
    ×èòàòåëü Íåäóã.Ðó
    Äëÿ ýòîãî ñóùåñòâóåò Ìåäëàéí, ñì. www.pubmed.gov

  2. mari111111
    #32
    ×èòàòåëü Íåäóã.Ðó
    Áîëüøîå ñïàñèáî!

  3. Ëèçà
    #33
    ×èòàòåëü Íåäóã.Ðó
     ïðèíöèïå îïåðàöèè ïî ïîâîäó âàðèêîöåëå âîîáùå íå èìåþò ñìûñëà. Òàêîãî òèïà îïåðàöèè ïàòîãåíåòè÷åñêè íå îáîñíîâàíû è îæèäàòü ïîëîæèòåëüíûõ ðåçóëüòàòîâ - òåøèòü ñåáÿ èëëþçèÿìè.

    Áîëåâîé ñèíäðîì ïîñëå ïåðåñå÷åíèÿ ÿè÷êîâîé âåíû äîâîëüíî îáû÷íîå ÿâëåíèå è ìîæåò áåñïîêîèòü ïàöèåíòà â òå÷åíèå äîñòàòî÷íî äîëãîãî âðåìåíè. Ñïåöèàëüíîãî ëå÷åíèÿ íå ñóùåñòâóåò. Ïîìîãàåò ïîêîé, íîøåíèå ïëîòíûõ òðóñîâ.  ñëó÷àå âîçíèêíîâåíèÿ ðåöèäèâà âàðèêîöåëå ìîãóò ïðåäëîæèòü ïîâòîðíóþ îïåðàöèþ. Íà ýòî ñîãëàøàòüñÿ íå ñëåäóåò. Âàðèêîöåëå ÿâëÿåòñÿ âàðèàíòîì íîðìû è ñàìîñòîÿòåëüíî ïðîõîäèò, îáû÷íî ê 30-35 ãîäàì.

    Àëåêñàíäð Ïåðøóêîâ

  4. Îëÿ
    #34
    ×èòàòåëü Íåäóã.Ðó
    Óâàæàåìûé ä-ð Ïåðøóêîâ,

    Ñêàæèòå ïîæàëóéñòà à ÷òî Âàì ïîçâîëÿåò áûòü ñòîëü áåçàïåëÿöèîííûì? Âû ãîâîðèòå êàê îòðóáàåòå: "âàðèêîöåëå âàðèàíò íîðìû", "îïåðàöèè ïàòîãåíåòè÷åñêè íå îáîñíîâàíû". Ýòî Âàøå ëè÷íîå àïðèîðíîå ìíåíèå, îñíîâàííîå íà òåîðåòè÷åñêèõ äîïóùåíèÿõ? Èëè ìîæåò Âû êàêèå íèáóäü èññëåäîâàíèÿ ïðîâåëè, êîòîðûå â ðåôåðèðóåìûõ æóðíàëàõ áûëè îïóáëèêîâàíû è ýòî Âàøå ìíåíèå áûëî ðàçäåëåíî êîëëåãàìè-ýêñïåðòàìè ïî äàííîé ïðîáëåìå â ñâÿçè ñ òåì, ÷òî Âû ïðåäñòàâèëè ÄÎÑÒÎÂÅÐÍÛÅ äàííûå? Íà ñåãîäíÿøíèé äåíü óñòàíîâëåíà ñâÿçü ìåæäó âàðèêîöåëå è áåñïëîäèåì, à òàêæå ìåæäó âàðèêîöåëå è àòðîôèåé ÿè÷êà (äàííûå êóðóïíîìàñøòàáíûõ èññëåäîâàíèé ïîä ýãèäîé ÂÎÇ, 1992). Ñêàæèòå, à ìóæñêîå áåñïëîäèå è àòðîôèÿ ÿè÷êà ýòî òîæå âàðèàíòû íîðìû? È õîòÿ ñåãîäíÿ âîïðîñ î òîì, âëèÿåò ëè ïîëîæèòåëüíî êîððåêöèÿ âàðèêîöåëå íà óâåëè÷åíèå ÷àñòîòû áåðåìåííîñòåé ó áåñïëîäíûõ ïàð ïðîäîëæàåò äèñêóòèðîâàòüñÿ, äóìàþ, ÷òî ãîâîðèòü î áåñïîëåçíîñòè êîððåêöèè âàðèêîöåëå ñ òî÷êè çðåíèÿ óëó÷øåíèÿ ôåðòèëüíîñòè ïîêà áûëî áû íå êîððåêòíûì.

  5. lajf
    #35
    ×èòàòåëü Íåäóã.Ðó
    Óâàæàåìûé äîêòîð Æèâîâ,

    òùàòåëüíûé àíàëèç ëèòåðàòóðû çà 150 ëåò (íà÷èíàÿ ñ 1852ã), îòå÷åñòâåííîé è çàðóáåæíîé; íåñîñòîÿòåëüíîñòü îñíîâíûõ ïîëîæåíèé ("ðåòðîãðàäíûé òîê" ïî ÿè÷êîâîé âåíå - òàê íàçûâàåìûé ñ-ì Âàëüñàëüâà); íåïàòîãåíåòè÷íîñòü îïåðàöèè high ligation; ñîáñòâåííûå îòäàëåííûå ðåçóëüòàòû ëå÷åíèÿ áíåñïëîäèÿ ïðè âàðèêîöåëå - êàê îïåðàòèâíûì ìåòîäîì òàê è êîíñåðâàòèâíûì; êîíôëèêòíîñòü èññëåäîâàíèé ÂÎÇ, êîòîðûå âñëåäñòâèå ñâîåé êîíôëèêòíîñòè òàê è íå áûëè îïóáëèêîâàíû (Hargreave; Nieschlag); ìíåíèå ïðîôåññîðà Â.Ñ.Êàðïåíêî; óòâåðæäåíèå ïðîô.Nieschlag î òîì, ÷òî "îïåðàöèÿ ïî ïîâîäó âàðèêîöåëå òàê æå ýôôåêòèâíà, êàê è ðàçãîâîðû î íåé".

    Äàííûå êîòîðûå îïóáëèêîâàíû â ìîíîãðàôèè "Âàðèêîöåëå" äîñòîâåðíû, ñòàòèñòè÷åñêèé àíàëèç ïðîâåäåí òùàòåëüíî è ïðàâèëüíûìè èíñòðóìåíòàìè. Êíèãà ïèñàëàñü 5 ëåò è ÿ ïðàêòè÷ñêè ïðî÷èòàë ïî÷òè âñå, ÷òî áûëî íàïèñàíî ïðî âàðèêîöåëå.

    Âàø âîïðîñ ïî ïîâîäó àòðîôèè ÿè÷êà êàê âàðèàíòà íîðìû íåêîððåêòåí, ïîñêîëüêó ðå÷ü èäåò íå îá àòðîôèè ÿè÷êà, à î âàðèêîöåëå, è ïî-ìîåìó ÿ íè÷åì Âàñ íå îñêîðáèë.

  6. Êðóòèçàíêà
    #36
    ×èòàòåëü Íåäóã.Ðó
    Óâàæàåìûé ä-ð Ïåðøóêîâ,

    Âî ïåðâûõ ëè÷íî ìåíÿ Âû êîíå÷íî íå îñêîðáèëè è ðàçãîâîð âîîáùå íå î ëè÷íîì. Íàäåþñü, ÷òî è òî, ÷òî àäðåñóåòñÿ ìíîþ Âàì òàêæå íå âûçûâàåò ó Âàñ ëè÷íîé íåïðèÿçíè.



    À äåëî â ñëåäóþùåì. Ñ ïîçèöèé äîêàçàòåëüíîé ìåäèöèíû î äîñòîâåðíîñòè èññëåäîâàíèé ìîæíî ãîâîðèòü òîëüêî åñëè îíè áûëè ðàíäîìèçèðîâàííûìè è êîíòðîëèðóåìûìè (ÐÊÈ). Ëè÷íîå ìíåíèå êàê òàêîâîå, Âàøå è äðóãèõ óâàæàåìûõ êîëëåã ýòî ëèøü Âàøè ëè÷íûå ìíåíèÿ, óðîâåíü äîêàçàòåëüíîñòè êîòîðûõ ñàìûé íèçêèé.  òî æå âðåìÿ èìååòñÿ ìíåíèå êîíñåíñóñà Àìåðèêàíñêîé óðîëîãè÷åñêîé Àññîöèàöèè, ñîñòîÿùåãî èç ýêñïåðòîâ ñ ìèðîâûì èìåíåì, âûðàæåííîå â âèäå Ðåêîìåíäàöèé ïî äèàãíîñèòèêå è ëå÷åíèþ Âàðèêîöåëå ñâÿçàííîãî ñ áåñïëîäèåì (http://www.auanet.org/timssnet/products/guidelines/main_reports/varicoceleinfertility.pdf). Ðàáîòàâøèé êîëëåêòèâ ýêñïåðòîâ, àíàëèçèðîâàë íàèáîëåå äîñòîâåðíóþ ëèòåðàòóðó, à òàêæå äàííûå ñîáñòâåííûõ èññëåäîâàíèé è îïûòà. Âû ñ÷èòàåòå, ÷òî Âàøå ìíåíèå, Âàøè èññëåäîâàíèÿ è îïûò áîëåå äîñòîâåðíî? Õîðîøî, òîãäà ïîæàëóéñòà ñîîáùèòå áûëè ëè îïóáëèêîâàíû Âàøè ðàáîòû, ðàáîòû ïðîô. Â.Ñ. Êàðïåíêî èëè ïðîô. Nieschlag, ïîääåðæèâàþùèå Âàøó ïîçèöèþ, â êàêèõ-ëèáî çàïàäíîåâðîïåéñêèõ èëè àìåðèêàíñêèõ ðåôåðèðóåìûõ æóðíàëàõ? Åñëè äà, ïîæàëóéñòà äàéòå ññûëêè è ïîçâîëüòå ñ íèìè îçíàêîìèòüñÿ. Èëè êàê ìèíèìóì ïîæàëóéñòà ïðèâåäèòå àáñòðàêò õîòÿ áû îäíîãî íåîïóáëèêîâàííîãî ÐÊÈ (âûïîëíåííîãî Âàìè èëè êåì-ëèáî), ðåçóëüòàòû êîòîðîãî ïîääåðæèâàþò Âàøó ïîçèöèþ.



    È åùå. Âû íå ñîãëàñíû ñ òåì, ÷òî àòðîôèÿ ÿè÷êà íàñòóïàåò â ðåçóëüòàòå âàðèêîöåëå (íàðóøåíèÿ òðîôèêè, ãèïîêñèÿ, ïîâûøåíèå òåìïåðàòóðû ÿè÷êà)?



    Ñ óâàæåíèåì

  7. Grebensky
    #37
    ×èòàòåëü Íåäóã.Ðó
    Óâàæàåìûé ä-ð Æèâîâ,

    Hargreave T.B.: Varicocele: overview and commentary on the results of the World Health Organization varicocele trial. In Waites G.M.H., Frick J. and Baker G.W.H. (eds). "Current Advances in Andrology", Proceedings of the VIth International Congress of Andrology. Salzburg, Monduzzi Editore, Bologna, 31-44.



    Lenzi A., Gandini L., Bagolan P., Nahum A., Dondero F.: Sperm parameters after early left varicocele treatment. Fertil. Steril., 69: 347-349, 1998.



    Nieschlag E., Hertle L., Fischedick A., Behre H.M.: Treatment of Varicocele: Counselling as Effective as Occlusion of the Vena Spermatica. Annual Meeting of the Pacific Coast Fertility Society, held April 26-30, 1995 in Coronado, California.



    Nieschlag E., Behre H.M., Meschede D., Kamischke A.: Disoders and the testicular level. In Nieschlag E. and Behre H.M. (Eds), Andrology: Male Reproductive Health and Dysfunction. Springer, Heidelberg, pp. 133-159, 1997.



    Nieschlag E., Hertle L., Fischedick A., Abshagen K., Behre H.M.: Update on treatment of varicocele: counselling as effective as occlusion of the vena spermatica. Hum. Reprod., 13: 2147-2150, 1998.



    À ìîå ëè÷íîå ìíåíèå î âëèÿíèè âàðèêîöåëå íà àòðîôèþ ÿè÷êà è ò.ä. Âû ìîæåòå óçíàòü èç ìîåé êíèãè. Ïîâåðüòå, âîïðîñû âàðèêîöåëå ñëèøêîì ñëîæíû è ñåðüåçíû, ÷òîáû èõ ìîæíî áûëî ðåøèòü ïóòåì ýëåêòðîííîé äèñêóññèè.

     êíèãå ðàññìîòðåíû ñàìûå ïðîòèâîïîëîæíûå è ïðîòèâîðå÷èâûå ìíåíèÿ ó÷åíûõ èç ñàìûõ ðàçíûõ ñòðàí, â ò.÷. è âåäóùèõ àìåðèêàíñêèõ èññëåäîâàòåëåé.

    Ðàáîòû M.Goldstein'a íàì êîíå÷íî èçâåñòíû, à åãî îïåðàòèâíûé ìåòîä ëå÷åíèÿ âàðèêîöåëå ñ âûâîðà÷èâàíèåì ÿè÷êà âðÿä ëè ïîëó÷èò ðàñïðîñòðàíåíèå.

    Ñ óâàæåíèåì

    Àëåêñàíäð Ïåðøóêîâ

  8. Åâãåíèé Ìóëèê
    #38
    ×èòàòåëü Íåäóã.Ðó
    Óâàæàåìûé À.Ïåðøóêîâ, ñïàñèáî çà ñîäåðæàòåëüíóþ ìîíîãðàôèþ. Ñ÷èòàþ, äàííàÿ òåìà î÷åíü äèñêóòàáåëüíà. Ä-ð Æèâîâ ñòîðîííèê àìåðèêàíñêîãî ïîäõîäà ê ëå÷åíèþ âàðèêîöåëå, íî ãäå èñòèíà? Åñòü î÷åíü ìíîãî ñïîðíûõ ìîìåíòîâ. È ïîêà â Ðîññèè íå áóäóò ñîçäàíû ñòàíäàðòû , äî òåõ ïîð áóäóò ñóùåñòâîâàòü ðàçëè÷íûå òî÷êè çðåíèÿ è ðàçëè÷íûå ïîäõîäû ê äàííîé ïðîáëåìå. Ìîæåò ñòîèò îáñóäèòü íà Ïëåíóìå Ïðàâëåíèÿ Ðîññèéñêîãî îáùåñòâà óðîëîãîâ?

  9. zizi
    #39
    ×èòàòåëü Íåäóã.Ðó
    Óâàæàåìûé ä-ð Àëåêñàíäð (íå çíàþ ê ñîæàëåíèþ Âàøåãî îò÷åñòâà) Ïåðøóêîâ. Ñïàñèáî çà ïðèâåäåííûå ññûëêè.



    Èòàê, ðàáîòà Lenzi A. et al.á 1998

    Àâòîðû ïèøóò ñëåäóþùåå:

    1. The mean values of sperm parameters in the patient study group were similar to those of the healthy controls except that the sperm concentration was significantly lower.

    Ýòî ïåðåâîäèòñÿ íà ðóññêèé ÿçûê òàê: "Ñðåäíèå çíà÷åíèÿ ïàðàìåòðîâ ñïåðìîãðàììû èññëåäóåìîé ãðóïïû ïàöèåíòîâ íå îòëè÷àëèñü îò êîíòðîëüíîé ãðóïïû çäîðîâûõ, çà èñêëþ÷åíèåì òîãî, ÷òî (ó ïàöèåíòîâ) êîíöåíòðàöèÿ ñïåðìàòîçîèäîâ áûëà çíà÷èòåëüíî íèæå".

    2. However, sperm motility and morphology mean values in the patient study group were significantly higher than those of the unoperated patients.

    Ïåðåâîä: "Òåì íå ìåíåå ñðåäíèå ïîêàçàòåëè ïîäâèæíîñòè è ìîðôîëîãèè ñïåðìàòîçîèäîâ ó ïàöèåíòîâ èññëåäóåìîé ãðóïïû áûëè çíà÷èòåëüíî âûøå, ÷åì ó íåîïåðèðîâàííûõ ïàöèåíòîâ".

    3. CONCLUSION(S): This study indicates that surgery in adolescence can be useful, possibly because the testis is developing at that age. Large-scale, double-blind controlled trials on early treatment of left varicocele are needed to identify possible markers of disease severity.

    Ïåðåâîä: "Âûâîäû: Äàííîå èññëåäîâàíèå ïîêàçûâàåò, ÷òî îïåðàöèè ó ïîäðîñòêîâ ìîãóò áûòü ïîëåçíûìè, âîçìîæíî ïîòîìó, ÷òî ÿè÷êî ðàçâèâàåòñÿ â ýòîì âîçðàñòå. Áîëåå îáøèðíûå, äâîéíûå ñëåïûå êîíòðîëèðóåìûå èññëåäîâàíèÿ ëåâîñòîðîííåãî âàðèêîöåëå íåîáõîäèìû äëÿ òîãî, ÷òîáû èäåíòèôèöèðîâàòü âîçìîæíûå ìàðêåðû òÿæåñòè çàáîëåâàíèÿ".

    Âîò ññûëêà íà àáñòðàêò ñòàòüè (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abs tract&list_uids=9496354).

    Èòàê, óâàæàåìûé Àëåêñàíäð (îïÿòü æå èçâèíèòå çà íåçíàíèå Âàøåãî îò÷åñòâà, ä-ðà A. Lenzi ñ ñîàâò., âî âñÿêîì ñëó÷àå ñóäÿ ïî öèòèðîâàííîé Âàì æå ñòàòüå, Âû ìîæåòå ñìåëî èñêëþ÷àòü èç ñâîèõ åäèíîìûøëåííèêîâ. Îíè îòñòàèâàþò äèàìåòðàëüíî ïðîòèâîïîëîæíóþ òî÷êó çðåíèÿ î òîì, ÷òî âàðèêîöåëå óìåíüøàåò ïîêàçàòåëè ôåðòèëüíîñòè è ÷òî äàííîå çàáîëåâàíèå ñëåäóåò îïåðèðîâàòü â ïîäðîñòêîâîì âîçðàñòå. Âèäèìî Âû íåòî÷íî ïåðåâåëè ñòàòüþ, ëèáî ÷åãî òî íå ïîíÿëè.



    Òåïåðü ïî ñëåäóþùåìó àâòîðó. Íó âî ïåðâûõ who is Dr. Eberhard Nieschlag? À îí åñòü ðåïðîäóêòèâíûé ýíäîêðèíîëîã, êîòîðûé çàèíòåðåñîâàí â òîì, ÷òîáû áîëüíûå ìóæñêîé èíôåðòèëüíîñòüþ íå îïåðèðîâàëèñü, à ïîëó÷àëè íåêîå êîíñåðâàòèâíîå ëå÷åíèå èëè øëè íà IVF/ICSI. Êñòàòè, ä-ð Ïðåøóêîâ, Âàøå çàìå÷àíèå ïî ïîâîäó "âûâîðà÷èâàíèÿ ÿè÷êà" êàê ïðåïÿäñòâèÿ ê ðàñïðîñòðàíåíèþ îïåðàöèè M. Goldstein (ìû ñäåëàëè óæå áîëåå 100 ìèêðîõèðóðãè÷åñêèõ âàðèêîöåëýêòîìèé ïî ýòîìó àâòîðó) ãîâîðèò î òîì, ÷òî Âû âåðîÿòíî íå ñîâñåì õîðîøî ñåáå ïðåäñòàâëÿåòå ýòó îïåðàöèþ, ñêîðåå âñåãî íå âèäåëè êàê îíà äåëàåòñÿ è ÷åì âîîáùå îòëè÷àåòñÿ îò âûñîêèõ ëèãèðîâàíèé ÿè÷êîâîé âåíû ïî Èâàíèññåâè÷ó/Ïàëîìî. Åñëè ÿ îøèáàþñü ïîæàëóéñòà âñå æå ñîîáùèòå â ÷åì Âû âèäèòå îòëè÷èå îïåðàöèè M. Goldstein îò îïåðàöèé Ïàëîìî/Èâàíèññåâè÷à? Êàê ñïåöèàëèñòó ïî ëå÷åíèþ âàðèêîöåëå ýòà ðàçíèöà äîëæíà áûòü Âàì õîðîøî èçâåñòíà. Ðàâíî êàê è òî, çà÷åì ïðè îïåðàöèè M. Goldstein "âûâîðà÷èâàåòñÿ" ÿè÷êî (ýòî, êñòàòè, îòíþäü íå ÿâëÿåòñÿ îïðåäåëÿþùåé îñîáåííîñòüþ äàííîé îïåðàöèè).



    Èç åäèíñòâåííîé öèòèðîâàííîé Âàìè îïóáëèêîâàííîé â ðåôåðèðóåìîì æóðíàëå ðàáîòå ä-ðà Eberhard Nieschlag ñëåäóåò, ÷òî â êà÷åñòâå ëå÷åíèÿ âàðèêîöåëå èñïîëüçîâàëèñü îïåðàöèè âûñîêîãî ëèãèðîâàíèÿ èëè ýìáîëèçàöèè ÿè÷êîâîé âåíû. Ýòè îïåðàöèè êàê ðàç ïàòîãåíåòè÷åñêè ìàëî îáîñíîâàíû, ò.ê. îíè áëîêèðóþò âñåãî îäèí èç 5 âîçìîæíûõ êîëëåêòîðîâ ïàòîëîãè÷åñêîãî âåíîçíîãî îòòîîêà èç ÿè÷êà ïðè âàðèêîöåëå. Âî-âòîðûõ èñïîëüçîâàëñÿ âñåãî ëèøü 12 ìåñÿ÷íûé ñðîê íàáëþäåíèÿ ïîñëå îïåðàöèè, ÷òî ìîãëî áûòü íåäîñòàòî÷íûì. Â-òðåòüèõ â ðàáîòå àíàëèçèðîâàëàñü ÷àñòîòà íàñòóïëåíèÿ áåðåìåííîñòåé â ñåìåéíûõ ïàðàõ, ãäå èíôåðòèëüíîñòü áûëà ïî ïðè÷èíå ìóæñêîãî ôàêòîðà (?), à èìåâøàÿ ìåñòî ìóæñêàÿ èíôåðòèëüíîñòü áûëà ñâÿçàíà ñ âàðèêîöåëå (?). Çäåñü âîçíèêàåò âîïðîñ - à òîëüêî ëè âàðèêîöåëå áûëî ïðè÷èíîé èíôåðòèëüíîñòè â îáñëåäîâàííûõ ïàðàõ? Â-÷åòâåðòûõ íåïîíÿòíî ïî÷åìó íå ñðàâíèâàëèñü ïàðàìåòðû ñïåðìîãðàììû ó ïðîîïåðèðîâàííûõ è íåïðîîïåðèðîâàííûõ? Åñëè ïîñëå îïåðàöèè ïîêàçàòåëè ñïåðìîãðàììû óëó÷øèëèñü. òî âîçìîæíî áåðåìåííîñòü íå íàñòóïàëà ïî äðóãèì ïðè÷èíàì? Â-ïÿòûõ äàæå ïî äàííûì àâòîðà ðàáîòû, ÷àñòîòà áåðåìåííîñòåé â ãðóïïå ïðîîïåðèðîâàííûõ áûëà íà 4% âûøå (ñòàòèñòè÷åñêè íå çíà÷èìî). Âîçìîæíî ïðè óâåëè÷åíèè ÷èñëà íàáëþäåíèé - ðàçíèöà öâåëè÷èòñÿ è ñòàíåò ñòàòèñòè÷åñêè çíà÷èìîé?

    Èòàê äàííàÿ ðàáîòà ä-ðà Eberhard Nieschlag (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abs tract&list_uids=9756286) îòíþäü íå áåçïðå÷àí ïî äèçàéíó è ñêîðåå âûçûâàåò âîïðîñû, ÷åì äàåò ÿñíûå îòâåòû.



    Èòàê, â ñóõîì îñòàòêå ä-ð Àëåêñàíäð Ïåðøóêîâ + ä-ð Eberhard Nieschlag ñ îäíîé ñòîðîíû, ïðîòèâ îñòàëüíîãî óðîëîãè÷åñêîãî ìèðà ñ äðóãîé. Êñòàòè, äëÿ scorpio, ñòàíäàðòû ëå÷åíèÿ âàðèêîöåëå Åâðîïåéñêîé Óðîëîãè÷åñêîé Àññîöèàöèè ìàëî ÷åì îòëè÷àþòñÿ îò òàêîâûõ Àìåðèêàíñêîé Óðîëîãè÷åñêîé Àññîöèàöèè.



    Òåïåðü ñòàòüè â çàùèòó àêòèâíîãî õèðóðãè÷åñêîãî ëå÷åíèÿ âàðèêîöåëå è, â ÷àñòíîñòè òîãî, ÷òî âàðèêîöåëå ÿâëÿåòñÿ ïðè÷èíîé àòðîôèè ÿè÷êà (Âû, ä-ð Ïåðøóêîâ, íà ñâîåì ñàéòå öèòèðóåòå Á.Í. Õîëüöîâà îò 1927 ã., êîòîðûé ãîâîðèò î òîì, ÷òî àòðîôèÿ ÿè÷êà â ðåçóëüòàòå âàðèêîöåëå áûâàåò ðåäêî. Âû ñàìè íå ïîíèìàåòå àáñóðäíîñòü äàííîé öèòàòû?):



    Grober ED, Chan PT, Zini A, Goldstein M.

    Microsurgical treatment of persistent or recurrent varicocele. (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abs tract&list_uids=15374720)



    Kumar R, Gupta NP.

    Subinguinal microsurgical varicocelectomy: evaluation of the results. (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abs tract&list_uids=14646434)



    Ku JH, Son H, Kwak C, Lee SE, Lee NK, Park YH.

    Impact of varicocele on testicular volume in young men: significance of compensatory hypertrophy of contralateral testis. (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abs tract&list_uids=12352455)



    Cayan S, Akbay E, Bozlu M, Doruk E, Erdem E, Acar D, Ulusoy E.

    The effect of varicocele repair on testicular volume in children and adolescents with varicocele. (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abs tract&list_uids=12131361)



    Testini M, Miniello S, Piccinni G, Di Venere B, Lissidini G, Esposito E.

    Microsurgical treatment of varicocele in outpatients using the subinguinal approach. (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abs tract&list_uids=11721208)



    Ñavallaro G, Albanese V, Pollicino A.

    Effects of surgical repair of first degree varicocele on gonadal function and testicular atrophy] (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abs tract&list_uids=11396069)



    Akbay E, Cayan S, Doruk E, Duce MN, Bozlu M.

    The prevalence of varicocele and varicocele-related testicular atrophy in Turkish children and adolescents. (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abs tract&list_uids=10971279)



    È ýòî òîëüêî çà ïîñëåäíèé ïÿòîê ëåò è òî íå âñå. ×òî Âû îòâåòèòå íà ýòî, óâàæàåìûé ä-ð Ïåðøóêîâ.

  10. Àâàòàð äëÿ nedug55371 Íîâè÷îê
    ñîîáùåíèé
    14
    Âàðèêîöåëå ÿè÷êà ìîæåò â ðåäêèõ ñëó÷àÿõ ðàçâèâàòüñÿ, åñëè åñòü áëîêèðîâêà êðóïíûõ âåí âûøå æèâîòà. Ýòî, âåðîÿòíî, ïðîèñõîäèò ëèøü ó ìóæ÷èí ñòàðøå 40 ëåò. Íàïðèìåð, åñëè âàðèêîöåëå âäðóã ðàçâèâàåòñÿ ó ïîæèëîãî ÷åëîâåêà, ýòî ìîæåò óêàçûâàòü íà îïóõîëü ïî÷êè, êîòîðàÿ äàâèò íà âåíû. Åñëè âàðèêîöåëå ðàçâèâàåòñÿ â ïîäðîñòêîâîì âîçðàñòå, òî âàø âðà÷, âîçìîæíî, ïîñòàðàåòñÿ êîíòðîëèðîâàòü ðîñò ÿè÷åê. Íàïðèìåð, âàì íóæíî áóäåò ïðîõîäèòü åæåãîäíîå èçìåðåíèå ÿè÷åê. Ýòî ìîæåò ïîìî÷ü óòî÷íèòü, íîðìàëüíîãî îíè ðàçìåðà èëè íåò.

  11. Àâàòàð äëÿ uroleg2 êàòåãîðèÿ: ìåäèöèíñêèå ÝÊÑÏÅÐÒÛ, ìîäåðàòîðû, êîíñóëüòàíòû Nedug.Ru :::::
    ñîîáùåíèé
    3,830
    Áëîã1
    Öèòàòà Ñîîáùåíèå îò nedug55371 Ïîñìîòðåòü ñîîáùåíèå
    Âàðèêîöåëå ÿè÷êà ìîæåò â ðåäêèõ ñëó÷àÿõ ðàçâèâàòüñÿ, åñëè åñòü áëîêèðîâêà êðóïíûõ âåí âûøå æèâîòà. Ýòî, âåðîÿòíî, ïðîèñõîäèò ëèøü ó ìóæ÷èí ñòàðøå 40 ëåò. Íàïðèìåð, åñëè âàðèêîöåëå âäðóã ðàçâèâàåòñÿ ó ïîæèëîãî ÷åëîâåêà, ýòî ìîæåò óêàçûâàòü íà îïóõîëü ïî÷êè, êîòîðàÿ äàâèò íà âåíû. Åñëè âàðèêîöåëå ðàçâèâàåòñÿ â ïîäðîñòêîâîì âîçðàñòå, òî âàø âðà÷, âîçìîæíî, ïîñòàðàåòñÿ êîíòðîëèðîâàòü ðîñò ÿè÷åê. Íàïðèìåð, âàì íóæíî áóäåò ïðîõîäèòü åæåãîäíîå èçìåðåíèå ÿè÷åê. Ýòî ìîæåò ïîìî÷ü óòî÷íèòü, íîðìàëüíîãî îíè ðàçìåðà èëè íåò.
    Ñïàñèáî çà èíôîðìàöèþ.
    "...áëîêèðîâêà êðóïíûõ âåí âûøå æèâîòà..." - ýòî ñèëüíî! ...)))
    Âàëüäøòåéí Îëåã Ìèõàéëîâè÷,
    âðà÷-óðîëîã âûñøåé êàòåãîðèè.
    Ïðèåì: ïÿòíèöà ñ 9 äî 15, âîñêðåñåíüå ñ 15 äî 21
    Òåëåôîí àäìèíèñòðàòîðà "Êëèíèêè íà Âëàäèìèðñêîé": 306-43-66, 306-01-52

Êëèíèêà ñòîìàòîëîãèè è êîñìåòîëîãèè â Ìîñêâå

Ìåòêè ýòîé òåìû

Âàøè ïðàâà

  • Âû ìîæåòå ñîçäàâàòü íîâûå òåìû
  • Âû ìîæåòå îòâå÷àòü â òåìàõ
  • Âû íå ìîæåòå ïðèêðåïëÿòü âëîæåíèÿ
  • Âû íå ìîæåòå ðåäàêòèðîâàòü ñâîè ñîîáùåíèÿ
  •